Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.
作者信息
Bakris George, Sternlicht Hillel
机构信息
University of Chicago Medicine, Department of Medicine, American Heart Association Comprehensive Hypertension Center, Chicago, Illinois, USA.
Veterans Affairs Medical Center and Georgetown University, Washington, DC, USA.
出版信息
J Am Coll Cardiol. 2021 Mar 16;77(10):1300-1301. doi: 10.1016/j.jacc.2021.01.019.
Abstract
摘要
相似文献
1
Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control.
J Am Coll Cardiol. 2021 Mar 16;77(10):1300-1301. doi: 10.1016/j.jacc.2021.01.019.
2
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
Blood Press Monit. 2007 Dec;12(6):393-5. doi: 10.1097/MBP.0b013e3282f2b53d.
3
Nocturnal Hypertension: Neglected Issue in Comprehensive Hypertension Management.
Acta Med Indones. 2016 Jan;48(1):76-82.
4
Redefining Blood Pressure Assessment - The Role of the Ambulatory Blood Pressure Monitoring Study for Drug Safety.
Clin Pharmacol Ther. 2020 Jan;107(1):147-153. doi: 10.1002/cpt.1690. Epub 2019 Nov 30.
5
Blood pressure variability, cardiovascular risk and antihypertensive treatment.
J Hypertens Suppl. 1995 Dec;13(4):S27-34. doi: 10.1097/00004872-199512002-00005.
6
Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
Circulation. 2020 Mar 24;141(12):e650-e651. doi: 10.1161/CIRCULATIONAHA.119.045048. Epub 2020 Mar 23.
7
Evaluating the true prevalence of resistant hypertension.
Hypertension. 2011 Oct;58(4):e23; author reply e24-5. doi: 10.1161/HYPERTENSIONAHA.111.178111. Epub 2011 Aug 8.
8
Blood pressure variability: a confounder and a cardiovascular risk factor.
Hypertens Res. 2011 Feb;34(2):162-3. doi: 10.1038/hr.2010.223. Epub 2010 Nov 25.
9
Response to Letter Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".
Circulation. 2020 Mar 24;141(12):e652-e653. doi: 10.1161/CIRCULATIONAHA.120.045961. Epub 2020 Mar 23.
10
Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?
Clin Exp Nephrol. 2016 Feb;20(1):14-22. doi: 10.1007/s10157-015-1184-1. Epub 2015 Oct 22.
引用本文的文献
1
Time in target range for systolic blood pressure and stroke in people with and without diabetes: the Kailuan prospective cohort study.
Front Endocrinol (Lausanne). 2025 May 14;16:1537343. doi: 10.3389/fendo.2025.1537343. eCollection 2025.
2
Long-Term Time in Target Range for Systolic Blood Pressure Since Childhood and Midlife Arterial Stiffness.
JACC Asia. 2025 Jan 7;5(1):101-112. doi: 10.1016/j.jacasi.2024.10.021. eCollection 2025 Jan.
3
Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?
Hypertens Res. 2025 Feb;48(2):833-835. doi: 10.1038/s41440-024-02021-x. Epub 2024 Nov 14.
4
The association of out-of-office blood pressure time in target range with clinical outcomes.
Hypertens Res. 2025 Jan;48(1):420-422. doi: 10.1038/s41440-024-01918-x. Epub 2024 Sep 27.
5
Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring.
Front Med (Lausanne). 2024 Jun 26;11:1396962. doi: 10.3389/fmed.2024.1396962. eCollection 2024.
6
Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.
J Clin Hypertens (Greenwich). 2024 Jun;26(6):714-723. doi: 10.1111/jch.14816. Epub 2024 Apr 23.
7
Time in therapeutic range in context of blood pressure management.
Hypertens Res. 2024 Jan;47(1):200-202. doi: 10.1038/s41440-023-01457-x. Epub 2023 Oct 11.
8
Time in therapeutic range: timely in hypertension therapeutics?
J Hum Hypertens. 2023 Mar;37(3):244-247. doi: 10.1038/s41371-022-00800-y. Epub 2023 Jan 6.
9
Highlights of the 2022 Vietnamese Society of Hypertension guidelines for the diagnosis and treatment of arterial hypertension: The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA): The collaboration of the Vietnamese Society of Hypertension (VSH) task force with the contribution of the Vietnam National Heart Association (VNHA).
J Clin Hypertens (Greenwich). 2022 Sep;24(9):1121-1138. doi: 10.1111/jch.14580.
10
Guidance for the Interpretation of Continual Cuffless Blood Pressure Data for the Diagnosis and Management of Hypertension.
Front Med Technol. 2022 May 17;4:899143. doi: 10.3389/fmedt.2022.899143. eCollection 2022.
Zotero 插件